Fuse Science Technology Provides Superior Roll-On Alternative for $1.7 Billion Hormone Replacement Category

MIAMI LAKES, Fla. , June 27, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP) ( www.fusescience.com ), a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals announced today additional information regarding the results of their latest research that has emerged from continued clinical analysis during due diligence of the Company's technology as part of the active M&A process. Fuse Science's proprietary technology has demonstrated the successful delivery of Estradiol in a roll-on application at therapeutic levels through the epidermis.

Millions of women in the United States suffer from hormonal imbalance , whether it is early menopause, peri-menopause symptoms or premenstrual symptoms. The side effects of these hormone imbalances include hot flashes, night sweats, trouble sleeping and weight gain. All of these side effects are concerning to most aging women.